Reasonable recellularization of the decellularized pulmonary valve in vivo

脱细胞肺动脉瓣体内合理再细胞化

基本信息

  • 批准号:
    17390382
  • 负责人:
  • 金额:
    $ 7.08万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2007
  • 项目状态:
    已结题

项目摘要

Background and Objectives : Although various technologies to recellularize both allogenic/xenogenic decellularrized heart valves and tissue-engineered biodegradable scaffolds have been developed, adequate condition of the decellularized matrix scaffold for recellularization by recipient cells and mechanism of regeneration of these grafts remain to be elucidated. The purpose of this study was to find optimal decellularizing techniques for the heart valve from the point of the matrix structure and to evaluate the recellularization by recipient cells using piglet model in vivo.Adequate decellularization techniques= Newly developed ammonium hydroxide-triton method, even the 0.1% concentration of ammonium hydroxide, decellularized the heart valve tissue completely. Although the elastin and collagen fiber, which is the main matrix structure, was maintained with good condition by the ammonium hydroxide-triton method, most of glycosaminoglycan fiber has almost disappeared. Concerning on the di … More sappearance of glycosaminoglycan, further examination to preserve the glycosaminoglycan fiber will be required for better decellularization.Recellularization of the decellularized pulmonary valve in vivo : Porcine decellularized monocusp valve graft was implanted to the internal jugular vein of allogenic piglet model, and was harvested four weeks after implantation. Immunohistological examination showed that α-SMA positive cells migrated into the surface and inner layer of the graft tissue, and vWF positive cells covered the surface of it. Matrix structure of the graft seemed to be preserved, however, massive inflammatory cells infiltrated into the graft tissue.Discussion : We developed 0.1% ammonium hydroxide-triton method as an adequate decellularization technique from the point of matrix tissue preservation. These data on recellularization of the decellularized pulmonary valve implanted in vivo imply that recipient cells migrate into the graft with decellularized matrix scaffold. Concerning on reasonable recellularization of the graft, further examination to exclude the inflammatory cells infiltration and to function with good hemodynamics and durability will be required for better decellularization technology in future clinical use. Less
背景和目的:目前已有多种技术用于异体/异种脱细胞心脏瓣膜和组织工程化生物降解支架的再细胞化,但脱细胞基质支架适合受体细胞再细胞化的条件和移植物再生机制尚不清楚。本研究的目的是从基质结构的角度寻找最佳的心脏瓣膜脱细胞技术,并利用仔猪体内模型评价受体细胞的再细胞作用。Adequate脱细胞技术=新开发的氢氧化铵-Triton法,即使是0.1%的氢氧化铵浓度,心脏瓣膜组织也完全脱细胞。虽然用氢氧化铵-Triton法可使主要基质结构弹性蛋白和胶原纤维保持较好的状态,但糖胺聚糖纤维大部分已基本消失。关于Di…脱细胞肺动脉瓣体内再细胞化:将猪去细胞单瓣移植到同种异体仔猪模型的颈内静脉,4周后取材。免疫组织化学显示α-SMA阳性细胞迁移到移植物组织的表层和内层,vWF阳性细胞覆盖于移植物表面。结论:从基质组织保存的角度出发,0.1%氢氧化铵-Triton法是一种合适的脱细胞技术。这些关于体内植入的脱细胞肺动脉瓣再细胞化的数据表明,受体细胞在脱细胞基质支架上迁移到移植物中。关于移植物的合理再细胞化,需要进一步的检查以排除炎细胞的渗透,并具有良好的血流动力学和耐久性,以便更好地在未来的临床应用中应用。较少

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Recellularization of the decellularized pulmonary valve using piglet model in vivo
使用仔猪模型体内脱细胞肺动脉瓣的再细胞化
脱細胞化肺動脈弁再細胞化の検討 -ミニブタ移植モデルでの検討-
脱细胞肺动脉瓣再细胞化检查-小型猪移植模型检查-
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KITAGAWA Tetsuya其他文献

KITAGAWA Tetsuya的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KITAGAWA Tetsuya', 18)}}的其他基金

Effects of Transplanted Human Cord Blood-Mononuclear Cells on Pulmonary Hypertension in Immunodeficient Mice and Their Distribution
移植人脐带血单核细胞对免疫缺陷小鼠肺动脉高压的影响及其分布
  • 批准号:
    24390331
  • 财政年份:
    2012
  • 资助金额:
    $ 7.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Energy load reduction of expressway tunnel ventilation system using air suction induced by low pressure under running vehicle
车辆行驶时低压吸气降低高速公路隧道通风系统能耗
  • 批准号:
    19560475
  • 财政年份:
    2007
  • 资助金额:
    $ 7.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cryopreserved Heart Valves with Repaired Matrix Metabolism
具有修复基质代谢的冷冻保存心脏瓣膜
  • 批准号:
    13671392
  • 财政年份:
    2001
  • 资助金额:
    $ 7.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

IFN- γ预处理ADSC来源外泌体搭载聚乙 烯醇基水凝胶在网片重建术中的应用及 作用机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
NeuroRegen scaffold负载ChABC&Cetuximab移植对陈旧性脊髓损伤的修复作用及机制研究
  • 批准号:
    82372503
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
骨髓基质干细胞体外构建耳廓形态软骨
  • 批准号:
    30973131
  • 批准年份:
    2009
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目
预构血管化支架以构建大体积岛状组织工程化脂肪瓣的实验研究
  • 批准号:
    30901566
  • 批准年份:
    2009
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Engineering a 3D construct with perfusable and functional capillary networks using scaffold-free method
使用无支架方法设计具有可灌注和功能性毛细血管网络的 3D 结构
  • 批准号:
    24K21088
  • 财政年份:
    2024
  • 资助金额:
    $ 7.08万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
  • 批准号:
    10748479
  • 财政年份:
    2024
  • 资助金额:
    $ 7.08万
  • 项目类别:
SBIR Phase II: Microbe-based scaffold for the generation of structured cell-based meat
SBIR 第二阶段:用于生成结构化细胞肉的微生物支架
  • 批准号:
    2303802
  • 财政年份:
    2023
  • 资助金额:
    $ 7.08万
  • 项目类别:
    Cooperative Agreement
Thick silk fibroin vascular graft: a promising tissue engineered scaffold material for abdominal vein grafts in middle-sized mammals
厚丝素蛋白血管移植物:一种有前途的用于中型哺乳动物腹部静脉移植的组织工程支架材料
  • 批准号:
    23H02968
  • 财政年份:
    2023
  • 资助金额:
    $ 7.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
  • 批准号:
    10465010
  • 财政年份:
    2023
  • 资助金额:
    $ 7.08万
  • 项目类别:
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
  • 批准号:
    10550045
  • 财政年份:
    2023
  • 资助金额:
    $ 7.08万
  • 项目类别:
Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability
ATR 在跨损伤合成中的作用对预防 DNA 损伤诱导的突变和染色体不稳定性的影响
  • 批准号:
    10634852
  • 财政年份:
    2023
  • 资助金额:
    $ 7.08万
  • 项目类别:
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
免疫调节生物材料可增强 T 细胞对三阴性乳腺癌的反应
  • 批准号:
    10699815
  • 财政年份:
    2023
  • 资助金额:
    $ 7.08万
  • 项目类别:
Thiazolino-Pyridone Compounds as Novel Drugs for Tuberculosis
噻唑啉-吡啶酮化合物作为结核病新药
  • 批准号:
    10698829
  • 财政年份:
    2023
  • 资助金额:
    $ 7.08万
  • 项目类别:
Neural and Caregiver Contributions to the Development of Joint Attention
神经和护理人员对共同注意力发展的贡献
  • 批准号:
    10654153
  • 财政年份:
    2023
  • 资助金额:
    $ 7.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了